Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-08 09:25 am Purchase |
2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
STATE STREET CORP STT |
3,179,068 5.790% |
186,186 (+6.22%) |
Filing History |
| 2023-02-06 2:43 pm Purchase |
2022-12-30 | 13G | Agios Pharmaceuticals, Inc. AGIO |
WELLINGTON MANAGEMENT CO LLP | 5,462,657 9.940% |
314,091 (+6.10%) |
Filing History |
| 2023-01-25 10:36 am Sale |
2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
BLACKROCK INC BLK |
4,768,874 8.700% |
-735,122 (-13.36%) |
Filing History |
| 2022-10-06 08:37 am Sale |
2022-09-30 | 13G | Agios Pharmaceuticals, Inc. AGIO |
J P MORGAN CHASE & CO JPM |
1,491,001 2.700% |
-1,608,568 (-51.90%) |
Filing History |
| 2022-09-12 11:13 am Sale |
2022-09-09 | 13G | Agios Pharmaceuticals, Inc. AGIO |
FMR CORP | 2,007,111 3.661% |
-3,427,202 (-63.07%) |
Filing History |
| 2022-03-09 5:18 pm Purchase |
2022-02-28 | 13G | Agios Pharmaceuticals, Inc. AGIO |
BLACKROCK INC BLK |
5,503,996 10.100% |
95,460 (+1.76%) |
Filing History |
| 2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
PRICE T ROWE ASSOCIATES INC | 2,878,714 5.300% |
2,878,714 (New Position) |
Filing History |
| 2022-02-11 4:51 pm Purchase |
2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
BB BIOTECH AG | 4,312,292 7.900% |
153,390 (+3.69%) |
Filing History |
| 2022-02-09 4:36 pm Purchase |
2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
STATE STREET CORP STT |
2,992,882 5.510% |
2,992,882 (New Position) |
Filing History |
| 2022-02-09 3:16 pm Sale |
2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
The Vanguard Group | 5,068,590 9.330% |
-415,984 (-7.58%) |
Filing History |
| 2022-02-09 09:09 am Sale |
2022-02-08 | 13G | Agios Pharmaceuticals, Inc. AGIO |
FMR CORP | 5,434,313 10.006% |
-2,199,667 (-28.81%) |
Filing History |
| 2022-02-04 09:12 am Sale |
2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
WELLINGTON MANAGEMENT CO LLP | 5,148,566 9.480% |
-2,728,804 (-34.64%) |
Filing History |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
BLACKROCK INC BLK |
5,408,536 9.950% |
-523,124 (-8.82%) |
Filing History |
| 2022-01-19 12:37 pm Purchase |
2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
J P MORGAN CHASE & CO JPM |
3,099,569 5.700% |
3,099,569 (New Position) |
Filing History |
| 2021-12-09 1:54 pm Sale |
2021-11-30 | 13G | Agios Pharmaceuticals, Inc. AGIO |
The Vanguard Group | 5,484,574 10.100% |
-141,139 (-2.51%) |
Filing History |
| 2021-08-09 3:23 pm Purchase |
2021-07-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
BLACKROCK INC BLK |
5,931,660 10.100% |
1,446,660 (+32.26%) |
Filing History |
| 2021-04-05 5:26 pm Unchanged |
2021-04-05 | 13D | Agios Pharmaceuticals, Inc. AGIO |
BRISTOL MYERS SQUIBB CO BMY |
0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-03-10 09:46 am Purchase |
2021-03-09 | 13G | Agios Pharmaceuticals, Inc. AGIO |
FMR CORP | 7,633,980 10.968% |
3,295,314 (+75.95%) |
Filing History |
| 2021-02-12 4:11 pm Purchase |
2020-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
BB BIOTECH AG | 4,158,902 6.000% |
261,948 (+6.72%) |
Filing History |
| 2021-02-10 10:30 am Purchase |
2020-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
The Vanguard Group | 5,625,713 8.120% |
18,858 (+0.34%) |
Filing History |